TrialThe lancet. Diabetes & endocrinology2020

Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.

Per-Henrik Groop et al.PubMed ↗Publisher ↗

No numbers read from the abstract.